TCL Archive Is $45 Million Too Much to Spend on PR? NCAB Panel Weighs NCI Communications Budget December 7, 2012
TCL Archive FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer. July 27, 2007